Iminopyrimidinones: A novel pharmacophore for the development of orally active renin inhibitors

被引：6

作者：

McKittrick, Brian A. ^{[1
]}

Caldwell, John P. ^{[1
]}

Bara, Thomas ^{[1
]}

Boykow, George ^{[3
]}

Chintala, Madhu ^{[3
]}

Clader, John ^{[1
]}

Czarniecki, Michael ^{[1
]}

Courneya, Brandy ^{[6
]}

Duffy, Ruth ^{[3
]}

Fleming, Linda

Giessert, Rachel ^{[6
]}

Greenlee, William J. ^{[1
]}

Heap, Charles

Hong, Liwu ^{[1
]}

Huang, Ying ^{[1
]}

Iserloh, Ulrich ^{[1
]}

Josien, Hubert ^{[1
]}

Khan, Tanweer ^{[1
]}

Korfmacher, Walter ^{[4
]}

Liang, Xian ^{[1
]}

Mazzola, Robert ^{[1
]}

Mitra, Soumya ^{[6
]}

Moore, Kristina ^{[3
]}

Orth, Peter ^{[2
]}

Rajagopalan, Murali ^{[1
]}

Roy, Sudipta ^{[6
]}

Sakwa, Samuel ^{[6
]}

Strickland, Corey ^{[2
]}

Vaccaro, Henry ^{[1
]}

Voigt, Johannes ^{[2
]}

Wang, Hongwu ^{[2
]}

Wong, Jesse ^{[1
]}

Zhang, Rumin ^{[5
]}

Zych, Andrew ^{[6
]}

机构：

[1] Merck Res Labs, Discovery Chem, Kenilworth, NJ 07033 USA

[2] Merck Res Labs, Struct Chem, Kenilworth, NJ 07033 USA

[3] Merck Res Labs, Cardiovasc Pharmacol, Kenilworth, NJ 07033 USA

[4] Merck Res Labs, Pharmacokinet Pharmacodynam & Metab, Kenilworth, NJ 07033 USA

[5] Merck Res Labs, Biochem & Biophys, Kenilworth, NJ 07033 USA

[6] Albany Mol Res Inc, Dept Med Chem, Albany, NY 12203 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2015年 / 25卷 / 07期

关键词：

Renin inhibitors; BACE1; Hypertension; Structure-based drug design; Enzyme inhibitors; STRUCTURE-BASED DESIGN; BACE1; INHIBITORS; TRANSGENIC RATS; DRUG DISCOVERY; HYPERTENSION; ALISKIREN; POTENT; MANAGEMENT; VTP-27999; PART;

D O I：

10.1016/j.bmcl.2015.02.003

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The development of renin inhibitors with favorable oral pharmacokinetic profiles has been a longstanding challenge for the pharmaceutical industry. As part of our work to identify inhibitors of BACE1, we have previously developed iminopyrimidinones as a novel pharmacophore for aspartyl protease inhibition. In this letter we describe how we modified substitution around this pharmacophore to develop a potent, selective and orally active renin inhibitor. (C) 2015 Elsevier Ltd. All rights reserved.

引用

页码：1592 / 1596

页数：5

共 50 条

[41] A NEW CLASS OF ORALLY ACTIVE GLYCOL RENIN INHIBITORS CONTAINING PHENYLLACTIC ACID AT P-3
HANSON, GJ
BARAN, JS
LOWRIE, HS
RUSSELL, MA
SARUSSI, SJ
WILLIAMS, K
BABLER, M
BITTNER, SE
PAPAIOANNOU, SE
YANG, PC
WALSH, GM
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 160 (01) : 1 - 5
[42] A new synthesis of the orally active renin inhibitor aliskiren
Slade, Joel
Liu, Hui
Prashad, Mahavir
Prasad, Kapa
TETRAHEDRON LETTERS, 2011, 52 (33) : 4349 - 4352
[43] Discovery of Orally Active JNK Inhibitors
Satoh, Yoshitaka
INFLAMMATION RESEARCH, 2005, 54 : S134 - S135
[44] Practical synthesis of an orally active renin inhibitor aliskiren
Dong, H
Zhang, ZL
Huang, JH
Ma, RJ
Chen, SH
Li, G
TETRAHEDRON LETTERS, 2005, 46 (37) : 6337 - 6340
[45] Orally active γ-secretase inhibitors.
Olson, RE
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U941 - U941
[46] Novel Carbamates as Orally Active Acetylcholinesterase Inhibitors Found to Improve Scopolamine-Induced Cognition Impairment: Pharmacophore-Based Virtual Screening, Synthesis, and Pharmacology
Chaudhaery, Shailendra S.
Roy, Kuldeep K.
Shakya, Neeraj
Saxena, Gunjan
Sammi, Shreesh Raj
Nazir, Aamir
Nath, Chandishwar
Saxena, Anil K.
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (17) : 6490 - 6505
[47] Novel orally active NF-κB inhibitors for the treatment of inflammatory diseases
Leban, Johann
Wuzik, Andreas
Gotschlich, Astrid
Lemstra, Sylvia
Kissel, Maria
Doblhofer, Robert
Strobl, Stefan
Hamm, Svetlana
CYTOKINE, 2007, 39 (01) : 22 - 23
[48] Discovery of a Novel Class of Orally Active Trypanocidal N-Myristoyltransferase Inhibitors
Brand, Stephen
Cleghorn, Laura A. T.
McElroy, Stuart P.
Robinson, David A.
Smith, Victoria C.
Hallyburton, Irene
Harrison, Justin R.
Norcross, Neil R.
Spinks, Daniel
Bayliss, Tracy
Norval, Suzanne
Stojanovski, Laste
Torrie, Leah S.
Frearson, Julie A.
Brenk, Ruth
Fairlamb, Alan H.
Ferguson, Michael A. J.
Read, Kevin D.
Wyatt, Paul G.
Gilbert, Ian H.
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (01) : 140 - 152
[49] Discovery of SPH3127: A Novel, Highly Potent, and Orally Active Direct Renin Inhibitor
Iijima, Daisuke
Sugama, Hiroshi
Takahashi, Yoichi
Hirai, Miki
Togashi, Yuko
Xie, Jianshu
Shen, Jingkang
Ke, Ying
Akatsuka, Hidenori
Kawaguchi, Takayuki
Takedomi, Kei
Kashima, Akiko
Nishio, Masashi
Inui, Yosuke
Yoneda, Hikaru
Xia, Guangxin
Iijima, Toru
JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (16) : 10882 - 10897
[50] Design and optimization of renin inhibitors: Orally bioavailable alkyl amines
Tice, Colin M.
Xu, Zhenrong
Yuan, Jing
Simpson, Robert D.
Cacatian, Salvacion T.
Flaherty, Patrick T.
Zhao, Wei
Guo, Joan
Ishchenko, Alexey V.
Singh, Suresh B.
Wu, Zhongren
Scott, Boyd B.
Bukhtiyarov, Yuri
Berbaum, Jennifer
Mason, Jennifer
Panemangalore, Reshma
Cappiello, Maria Grazia
Harrison, Richard K.
McGeehan, Gerard
Dillard, Lawrence W.
Baldwin, John J.
Claremon, David A.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237

← 1 2 3 4 5 →